三個皮匠報告
政策庫
new
付費
搜索

近5年起仿制藥一致性評價通過數量快速增長（個）-行業數據

近5年起仿制藥一致性評價通過數量快速增長（個）
近5年起仿制藥一致性評價通過數量快速增長（個）
公司首次覆蓋報告 2016 年，國家出臺《國務院辦公廳關于開展仿制藥質量和療效一致性評價的意見》等一系列政策，仿制藥評審標準提升，ANDA 申報與獲批數量銳減。隨著多輪集采的不斷推進，一致性評價申請數量快速增長，通過一致性評價（包含視同通過）的仿制藥數量從 2018年的 152個快速增加至 2022年的 1815個；同時，ANDA的申報數量與獲批數量也分別從 2018年的 750/496個增加至 2022年的 2244/1004個，對
其它 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?1KB 圖片尺寸：1212*866
同報告圖片
 / 41
近5年起仿制藥一致性評價通過數量快速增長（個）_第1頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第2頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第3頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第4頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第5頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第6頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第7頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第8頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第9頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第10頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第11頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第12頁
fCDlubTku70gfCDlhajnkIPvvIjljZXkvY3vvJrkur/nvo7lhYPvvIkgfCDkuK3lm73vvIjljZXkvY3vvJrkur/lhYPvvIkgfCDlhajnkIN5b3kgfCDkuK3lm715b3kgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCAyMDE3IHwgNDAwMCAgICAgICAgICAgICAgICAgfCA2MDAwICAgICAgICAgICAgIHwgLSAgICAgICAgfCAtICAgICAgICB8CnwgMjAxOCB8IDUwMDAgICAgICAgICAgICAgICAgIHwgNzAwMCAgICAgICAgICAgICB8IC0gICAgICAgIHwgLSAgICAgICAgfAp8IDIwMTkgfCA2MDAwICAgICAgICAgICAgICAgICB8IDgwMDAgICAgICAgICAgICAgfCAtICAgICAgICB8IC0gICAgICAgIHwKfCAyMDIwIHwgNzAwMCAgICAgICAgICAgICAgICAgfCA5MDAwICAgICAgICAgICAgIHwgLSAgICAgICAgfCAtICAgICAgICB8CnwgMjAyMSB8IDgwMDAgICAgICAgICAgICAgICAgIHwgMTAwMDAgICAgICAgICAgICB8IC0gICAgICAgIHwgLSAgICAgICAgfAp8IDIwMjJFfCA5MDAwICAgICAgICAgICAgICAgICB8IDExMDAwICAgICAgICAgICAgfCAtICAgICAgICB8IC0gICAgICAgIHwKCui1hOaWmeadpea6kO+8mkZyb3N0ICYgU3VsbGl2YW7jgIHlvIDmupDor4HliLjnoJTnqbbmiYAg5rOo77yaMjAyMC0yMDIx5bm05YWo55CD5pWw5o2u55SxRnJvc3QgJiBTdWxsaXZhbumihOS8sA==
近5年起仿制藥一致性評價通過數量快速增長（個）_第13頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第14頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第15頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第16頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第17頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第18頁
5qC55o2u5oKo5o+Q5L6b55qE5L+h5oGv77yM5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u55Sf5oiQ55qE6KGo5qC85Lul5Y+K55u45bqU55qE6LWE5paZ5p2l5rqQ77yaCgp8IOiBjOS9jSAgICAgICAgICB8IOS6uuaVsCB8CnwtLS0tLS0tLS0tLS0tLS18LS0tLS0tfAp8IOmUgOWUruS6uuWRmCAgICAgIHwgMTMgICB8Cnwg5oqA5pyv5Lq65ZGYICAgICAgfCAzODkgIHwKfCDotKLliqHkurrlkZggICAgICB8IDEwICAgfAp8IOe7vOWQiOeuoeeQhuS6uuWRmCAgfCAzMyAgIHwKCui1hOaWmeadpea6kO+8mldpbmTvvIzlvIDmupDor4HliLjnoJTnqbbmiYA=
近5年起仿制藥一致性評價通過數量快速增長（個）_第19頁
5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u77yM55Sf5oiQ55qE6KGo5qC85aaC5LiL77yaCgp8IOWtpuWOhiAgICAgfCDkurrmlbAgfAp8LS0tLS0tLS0tLXwtLS0tLS18Cnwg5aSn5LiT5Y+K5Lul5LiLIHwgNTEgICB8Cnwg5pys56eRICAgICB8IDMzMCAgfAp8IOehleWjq+WPiuS7peS4iiB8IDY0ICAgfAoK6LWE5paZ5p2l5rqQ77yaV2luZO+8jOW8gOa6kOivgeWIuOeglOeptuaJgA==
近5年起仿制藥一致性評價通過數量快速增長（個）_第20頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第21頁
fCDlubTku70gfCDmgLvokKXmlLbvvIjnmb7kuIflhYPvvIkgfCB5b3kgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS18CnwgMjAxOSB8IDEwMC4wMCAgICAgICAgICAgfCAtICAgIHwKfCAyMDIwIHwgMTUwLjAwICAgICAgICAgICB8IC0gICAgfAp8IDIwMjEgfCAyMDAuMDAgICAgICAgICAgIHwgLSAgICB8CnwgMjAyMiB8IDI1MC4wMCAgICAgICAgICAgfCAtICAgIHwKfCAyMDIzIHwgMzUwLjAwICAgICAgICAgICB8IC0gICAgfAp8IDIwMjRRMSB8IDEwMC4wMCAgICAgICAgICAgfCAtICAgIHwKCui1hOaWmeadpea6kO+8mldpbmTjgIHlvIDmupDor4HliLjnoJTnqbbmiYA=
近5年起仿制藥一致性評價通過數量快速增長（個）_第22頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第23頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第24頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第25頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第26頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第27頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第28頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第29頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第30頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第31頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第32頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第33頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第34頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第35頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第36頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第37頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第38頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第39頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第40頁
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
近5年起仿制藥一致性評價通過數量快速增長（個）_第41頁
近5年起仿制藥一致性評價通過數量快速增長（個）_第42頁
所屬報告： 萬邦醫藥-公司首次覆蓋報告：立足臨床業務致力打造醫療健康CRO平臺-240604（25頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站